• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CMV 特异性 CD8+ T 细胞功能在慢性淋巴细胞白血病中未受损。

CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.

机构信息

Department of Hematology and.

出版信息

Blood. 2014 Jan 30;123(5):717-24. doi: 10.1182/blood-2013-08-518183. Epub 2013 Nov 18.

DOI:10.1182/blood-2013-08-518183
PMID:24246502
Abstract

In chronic lymphocytic leukemia (CLL), CD8(+) T cells exhibit features of exhaustion and impaired functionality. Yet, reactivations of latent viruses such as cytomegalovirus (CMV) are uncommon in untreated CLL, suggesting that antiviral responses are uncompromised. We analyzed phenotypical and functional characteristics of CMV-specific CD8(+) T cells in CLL patients in comparison with age-matched healthy controls (HCs). Despite increased expression of the inhibitory receptors PD1, CD160, and CD244 on total CD8(+) T cells in CLL, expression levels of these markers were decreased on CMV-tetramer(+)CD8(+) T cells. Second, cytokine production upon stimulation with both phorbol 12-myristate 13-acetate/ionomycin and CMV-peptide-loaded antigen-presenting cells was intact in CMV-tetramer(+)CD8(+) T cells. Third, CMV-tetramer(+)CD8(+) T cells of CLL patients and HCs were equally effective in killing CMV-peptide-loaded target cells. Finally, quantitative imaging flow cytometry revealed that the proportion of CD8(+) T cells forming immunologic synapses with CMV-peptide-loaded B cells was intact. In conclusion, despite evidence for global T-cell dysfunction in CLL, we show here that CLL-derived CMV-specific CD8(+) T cells display lower expression of exhaustion markers and are functionally intact. These data indicate that the changes in the T-cell compartment in CLL may be more heterogeneous than presently assumed.

摘要

在慢性淋巴细胞白血病 (CLL) 中,CD8(+) T 细胞表现出衰竭和功能受损的特征。然而,未经治疗的 CLL 中很少发生潜伏病毒(如巨细胞病毒 [CMV])的再激活,这表明抗病毒反应没有受到损害。我们分析了 CLL 患者与年龄匹配的健康对照者 (HC) 中 CMV 特异性 CD8(+) T 细胞的表型和功能特征。尽管 CLL 中总 CD8(+) T 细胞上抑制性受体 PD1、CD160 和 CD244 的表达增加,但 CMV-四聚体 (+) CD8(+) T 细胞上这些标志物的表达水平降低。其次,在用佛波醇 12-肉豆蔻酸 13-乙酸盐/离子霉素和 CMV 肽负载的抗原呈递细胞刺激后,CMV-四聚体 (+) CD8(+) T 细胞中的细胞因子产生完整。第三,CLL 患者和 HCs 的 CMV-四聚体 (+) CD8(+) T 细胞在杀伤 CMV 肽负载的靶细胞方面同样有效。最后,定量成像流式细胞术显示,与 CMV 肽负载 B 细胞形成免疫突触的 CD8(+) T 细胞的比例完整。总之,尽管 CLL 中存在整体 T 细胞功能障碍的证据,但我们在这里表明,CLL 衍生的 CMV 特异性 CD8(+) T 细胞表现出较低的衰竭标志物表达水平,并且功能完整。这些数据表明,CLL 中 T 细胞区室的变化可能比目前假设的更为异质。

相似文献

1
CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.CMV 特异性 CD8+ T 细胞功能在慢性淋巴细胞白血病中未受损。
Blood. 2014 Jan 30;123(5):717-24. doi: 10.1182/blood-2013-08-518183. Epub 2013 Nov 18.
2
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病中巨细胞病毒特异性CD8+CD45RA+CD27- T细胞的扩增
Blood. 2003 Aug 1;102(3):1057-63. doi: 10.1182/blood-2003-01-0182. Epub 2003 Apr 10.
3
Hanging tough: CMV-specific CD8+ T cells in CLL.顽强抵抗:CLL 中的 CMV 特异性 CD8+T 细胞。
Blood. 2014 Jan 30;123(5):608-9. doi: 10.1182/blood-2013-12-540922.
4
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.慢性淋巴细胞白血病(CLL)患者的 T 细胞表现出 T 细胞耗竭的特征,但保留细胞因子产生的能力。
Blood. 2013 Feb 28;121(9):1612-21. doi: 10.1182/blood-2012-09-457531. Epub 2012 Dec 17.
5
Expanded antigen-experienced CD160CD8effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.在慢性淋巴细胞白血病中,扩增的抗原经历 CD160CD8effector T 细胞表现出受损的效应功能。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002189.
6
The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire.在患有 B 细胞慢性淋巴细胞白血病的患者中,巨细胞病毒特异性 CD4+T 细胞的数量明显扩增,并决定了总 CD4+T 细胞库。
Blood. 2010 Oct 21;116(16):2968-74. doi: 10.1182/blood-2009-12-257147. Epub 2010 Jun 18.
7
Cytomegalovirus-Induced Expression of CD244 after Liver Transplantation Is Associated with CD8+ T Cell Hyporesponsiveness to Alloantigen.肝移植后巨细胞病毒诱导的CD244表达与CD8⁺T细胞对同种异体抗原的低反应性相关。
J Immunol. 2015 Aug 15;195(4):1838-48. doi: 10.4049/jimmunol.1500440. Epub 2015 Jul 13.
8
Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.通过靶向CD20的HLA/巨细胞病毒复合物将巨细胞病毒特异性细胞毒性T淋巴细胞重定向至B细胞慢性淋巴细胞白血病。
Leukemia. 2006 Jun;20(6):1096-102. doi: 10.1038/sj.leu.2404185.
9
Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.同种异体移植后CD8(+)T细胞受体α库中存在大量巨细胞病毒(CMV)反应性克隆型。
Clin Exp Immunol. 2016 Jun;184(3):389-402. doi: 10.1111/cei.12770. Epub 2016 Mar 8.
10
Functional Differences Between EBV- and CMV-Specific CD8 T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL.EBV特异性和CMV特异性CD8 T细胞之间的功能差异表明慢性淋巴细胞白血病中T细胞功能障碍的异质性。
Hemasphere. 2020 Feb 13;4(2):e337. doi: 10.1097/HS9.0000000000000337. eCollection 2020 Apr.

引用本文的文献

1
CD19-ReTARG: A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing Malignancies.CD19靶向重定向:一种用于抗巨细胞病毒细胞毒性T细胞生理性靶向表达CD19的恶性肿瘤的新型融合蛋白。
Cancers (Basel). 2025 Jul 10;17(14):2300. doi: 10.3390/cancers17142300.
2
Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8+T cell responses in the absence of IL-2.在缺乏白细胞介素-2的情况下,调节CD226和PD-(L)1信号通路可改善巨细胞病毒特异性CD8+T细胞反应。
BMB Rep. 2025 Jul;58(7):307-312. doi: 10.5483/BMBRep.2025-0041.
3
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.
抗巨细胞病毒T细胞在癌症(免疫)治疗中的应用
Cancers (Basel). 2023 Jul 25;15(15):3767. doi: 10.3390/cancers15153767.
4
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.利用抗巨细胞病毒免疫进行局部免疫治疗实体瘤。
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2116738119. doi: 10.1073/pnas.2116738119. Epub 2022 Jun 24.
5
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells.维奈托克治疗可耗竭 CLL 细胞,从而逆转 CD4 T 细胞中的氧化应激和糖酵解受损。
Blood Adv. 2022 Jul 26;6(14):4185-4195. doi: 10.1182/bloodadvances.2022007034.
6
BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.BCL-2 表达通过增强调节性 T 细胞分化和细胞毒性 T 细胞耗竭促进慢性淋巴细胞白血病中的免疫抑制。
Mol Cancer. 2022 Feb 22;21(1):59. doi: 10.1186/s12943-022-01516-w.
7
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.慢性淋巴细胞白血病细胞对 NK 细胞介导的裂解的固有抗性可以通过抑制 Cdc42 诱导的肌动蛋白细胞骨架重塑来克服。
Front Immunol. 2021 May 24;12:619069. doi: 10.3389/fimmu.2021.619069. eCollection 2021.
8
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective.从表观遗传学角度探讨慢性淋巴细胞白血病中的 T 细胞功能障碍。
Haematologica. 2021 May 1;106(5):1234-1243. doi: 10.3324/haematol.2020.267914.
9
Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中的免疫功能紊乱及基于免疫的治疗干预。
Front Immunol. 2020 Nov 18;11:594556. doi: 10.3389/fimmu.2020.594556. eCollection 2020.
10
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.CD3xCD19 DART 分子治疗诱导非凋亡性杀伤,并且对高风险化疗和 venetoclax 耐药性慢性淋巴细胞白血病细胞有效。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000218.